Evidence map›Paper›PMID 11794168›Full record

Trial reportThe New England journal of medicine2001

Intensive insulin therapy in critically ill patients.

G van den Berghe, P Wouters, F Weekers, C Verwaest, F Bruyninckx, M Schetz, D Vlasselaers, P Ferdinande, P Lauwers, R Bouillon

21 registry-linked trialsOpen access · bronzeAbstract readClinical TrialRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in The New England journal of medicine, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 21 registered trials, which are not on this map. Cited by 2,155 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2,155citing papers in PubMed, 7 pooled it
174.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06187285 nacompletedstarted 2024, after this paper: background citation

Efficay and Safety of Empagliflozin Versus Sitagliptin for the In-patient Management of Hyperglycemia: Randomised Control

Ran2024Enrolled220Registered outcomes10Posted comparisons0ConditionsType 2 DiabetesArmsempagliflozin 25 mg, Sitagliptin 100mg
Open the trial in the graph
NCT00115479 phase2completednot on this mapstarted 2002, after this paper: background citation

KULeuven Intensive Insulin Therapy Study in Medical Intensive Care Patients

TypeinterventionalSponsorKU LeuvenRan2002 to 2005Enrolled1,200ConditionsCritical IllnessArmsintensive insulin therapy to maintain normoglycemia
NCT00177398 phase4completednot on this mapstarted 2005, after this paper: background citation

The Effect of Insulin Glargine on Glycemic Control, Morbidity, and Length of Stay in Hospitalized Subjects With Diabetes Receiving Enteral Nutrition

TypeinterventionalSponsorUniversity of PittsburghRan2005 to 2006Enrolled50ConditionsType 2 Diabetes, HyperglycemiaArmsGlargine insulin vs regular insulin
NCT00214916 phase2unknown statusnot on this mapstarted 2004, after this paper: background citation

KULeuven Intensive Insulin Study in Pediatric Intensive Care Patients

TypeinterventionalSponsorGreet Van den BergheRan2004 to 2023Enrolled700ConditionsCritical IllnessArmsintensive insulin therapy (Actrapid IV to normoglycemia), conventional insulin therapy (Actrapid IV only for excessive hyperglycemia)
NCT00240149 nacompletednot on this mapstarted 2005, after this paper: background citation

Pilot Study Evaluating Use of Insulin-Glucose Algorithm and Glucose Monitoring Techniques to Control Hyperglycemia in the Pediatric Intensive Care Unit

TypeinterventionalSponsorStanford UniversityRan2005 to 2006Enrolled0ConditionsHyperglycemiaArmsRegular Insulin via Insulin-Glucose Algorithm
NCT00248352 nacompletednot on this mapstarted 2005, after this paper: background citation

GLUCOSE : Glucose Lowering by Usual Care Or Specialized Endocrinology Team

TypeinterventionalSponsorOttawa Heart Institute Research CorporationRan2005 to 2007Enrolled169ConditionsDiabetes Mellitus, Type 2, Coronary DiseaseArmsConsultation with Endocrinologist, Counseling from Dietician, Counseling from Diabetes Educator, No intervention
NCT00282594 nacompletednot on this mapstarted 2003, after this paper: background citation

No Outcome Benefit for the Use of Intensive Insulin Therapy in the Critically Ill General and Vascular Surgical Patient. A Randomized Prospective Trial.

TypeinterventionalSponsorGenesysRan2003 to 2005Enrolled317ConditionsSepsis, Respiratory Failure, Renal Failure, Surgical Site InfectionArmsNovolin R (human recombinant Insulin)
NCT00328094 naterminatednot on this mapstarted 2006, after this paper: background citation

Impact of Tight Control of Perioperative Blood Glucose in Patients Undergoing Vascular Surgery on Their Perioperative Cardiovascular and Overall Morbidity and Mortality

TypeinterventionalSponsorBeth Israel Deaconess Medical CenterRan2006 to 2009Enrolled242ConditionsPeripheral Vascular Disease, Abdominal Aortic AneurysmArmscontinuous intravenous insulin infusion
NCT00370643 phase1completednot on this mapstarted 2002, after this paper: background citation

Intensive Glucose Control Versus Conventional:Tendency Of Better Clinical Outcome In Open Heart Surgery

TypeinterventionalSponsorUniversity of Sao PauloRan2002 to 2004Enrolled98ConditionsHyperglycaemia During Perioperative Period, Heart Valve Diseases, Ventricular DysfunctionArmshuman regular insulin
NCT00487162 naterminatednot on this mapstarted 2007, after this paper: background citation

The Association Between Peri-Operative Hyperglycemia and Major Morbidity and Mortality

TypeinterventionalSponsorUniversity of Medicine and Dentistry of New JerseyRan2007 to 2009Enrolled56ConditionsHyperglycemiaArmsintensive glycemic control, conventional glycemic control
NCT00512122 phase4active not recruitingnot on this mapstarted 2007, after this paper: background citation

Impact of Early Parenteral Nutrition Completing Enteral Nutrition in Adult Critically Ill Patients

TypeinterventionalSponsorKU LeuvenRan2007 to 2026Enrolled4,640ConditionsCritical Illness, StarvationArmsWithholding PN during the first week of ICU stay, Oliclinomel N71000 OR N71000E // Clinimix N17G35 OR N17G35E
NCT00732277 phase2completednot on this mapstarted 2008, after this paper: background citation

Evaluation of Corticosteroid Therapy in Childhood Severe Sepsis (Steroids in Paediatric Sepsis, StePS) - a Randomised Pilot Study

TypeinterventionalSponsorUniversity Hospital Southampton NHS Foundation TrustRan2008 to 2012Enrolled21ConditionsSepsisArmshydrocortisone
NCT00813280 completednot on this mapstarted 2008, after this paper: background citation

Barriers to the Implementation of Complete Insulin Order Sets in the Management of Individuals With Hyperglycemia or Diabetes at Park Nicollet Methodist Hospital

TypeobservationalSponsorHealthPartners InstituteRan2008 to 2008Enrolled200ConditionsHyperglycemia
NCT00878891 naterminatednot on this mapstarted 2009, after this paper: background citation

Real Time Continuous Glucose Monitoring With Glucoday® as an Assistant for Intensive Insulin Therapy in Diabetic Cardiothoracic Surgery Patients: a Randomized Study Comparing Blood Glucose Measurements Alone or Associated to Continue Glucose Monitoring

TypeinterventionalSponsorUniversity Hospital, BordeauxRan2009 to 2010Enrolled45ConditionsDiabetesArmsContinuous glucose monitoring for immediate correction of abnormal glycemia
NCT01176279 phase4unknown statusnot on this mapstarted 2008, after this paper: background citation

Randomised Clinical Trial to Evaluate the Obtention of Blood Samples Through an Arterial Catheter to Monitor Glycose Levels

TypeinterventionalSponsorConsorci Hospitalari de VicRan2008 to 2011Enrolled100ConditionsCritical Illness, HyperglycemiaArmsManual and automated washing of the peripherical lines, Automated washing of the peripherical lines
NCT01347801 nacompletednot on this mapstarted 2011, after this paper: background citation

Mechanisms of Insulin Resistance in Critical Illness: Role of Systemic Inflammation and GLP-1

TypeinterventionalSponsorRigshospitalet, DenmarkRan2011 to 2014Enrolled40ConditionsHypoglycaemiaArmsGLP-1, Placebo (Saline), TNF-alfa, OGTT, IVGTT
NCT01420302 nacompletednot on this mapstarted 2011, after this paper: background citation

LOGIC-Insulin Computerized Algorithm-guided Versus Nurse-directed Blood Glucose Control in Critically Ill Patients: the LOGIC-1 Randomized Controlled Trial

TypeinterventionalSponsorGreet Van den BergheRan2011 to 2012Enrolled300ConditionsCritical IllnessArmsNurse directed, LOGIC-Insulin
NCT02806999 phase4unknown statusnot on this mapstarted 2016, after this paper: background citation

The Therapeutic Effects of Combination of Insulin With Berberine on the Patients With Stess Hyperlipemia:a Prospective, Double Blind, Randomized, Placebo-controlled, Single-center Clinical Trial

TypeinterventionalSponsorGuangdong Provincial People's HospitalRan2016 to 2017Enrolled200ConditionsHyperglycemiaArmsBerberine, Insulin, Insulin
NCT03665207 phase3active not recruitingnot on this mapstarted 2018, after this paper: background citation

Impact of Tight Blood Glucose Control Within Normal Fasting Ranges With Insulin Titration Prescribed by the Leuven Algorithm in Adult Critically Ill Patients

TypeinterventionalSponsorKU LeuvenRan2018 to 2026Enrolled9,230ConditionsCritical Illness, HyperglycemiaArmsInsulin
NCT05135676 nacompletednot on this mapstarted 2022, after this paper: background citation

Time in Glucose Hospital Target (TIGHT) - A Randomized Clinical Trial to Evaluate the Use of CGM to Achieve a Mean Glucose Target of 90 to 130 mg/dL Without Hypoglycemia in Hospitalized Adults With Type 2 Diabetes

TypeinterventionalSponsorJaeb Center for Health ResearchRan2022 to 2024Enrolled169ConditionsDiabetes Mellitus, Type 2ArmsBlinded CGM, real-time CGM
NCT05710315 naactive not recruitingnot on this mapstarted 2025, after this paper: background citation

Single-center, Proof of Concept, Prospective Study Evaluating the Utility of RELiZORB™ for the Treatment of Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure

TypeinterventionalSponsorInova Health Care ServicesRan2025 to 2026Enrolled32ConditionsMulti Organ Failure, Exocrine Pancreatic InsufficiencyArmsRELiZORB™, Placebo
3 · Its place in the literature

Who cites it

2,155 citing papers in PubMed, 7 syntheses or guidelines pooled it, 9,986 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Randomized Study Comparing Continuous Glucose Monitoring and Capillary Glucose Testing in Patients With Type 2 Diabetes After Hospital Discharge.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2025
    Trial
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Postoperative hyperglycemia, nutritional recovery, and diabetes duration as predictors of complications after colorectal cancer surgery.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  18. Review
  19. Review
  20. Article

2,095 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

G van den BergheDepartment of Intensive Care Medicine, Catholic University of Leuven, Belgium. greta.vandenberghe@med.kuleuven.ac.be
P Wouters
F Weekers
C Verwaest
F Bruyninckx
M Schetz
D Vlasselaers
P Ferdinande
P Lauwers
R Bouillon
KU Leuven · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHyperglycemia and insulin resistance are common in critically ill patients, even if they have not previously had diabetes. Whether the normalization of blood glucose levels with insulin therapy improves the prognosis for such patients is not known.

methodsWe performed a prospective, randomized, controlled study involving adults admitted to our surgical intensive care unit who were receiving mechanical ventilation. On admission, patients were randomly assigned to receive intensive insulin therapy (maintenance of blood glucose at a level between 80 and 110 mg per deciliter [4.4 and 6.1 mmol per liter]) or conventional treatment (infusion of insulin only if the blood glucose level exceeded 215 mg per deciliter [11.9 mmol per liter] and maintenance of glucose at a level between 180 and 200 mg per deciliter [10.0 and 11.1 mmol per liter]).

resultsAt 12 months, with a total of 1548 patients enrolled, intensive insulin therapy reduced mortality during intensive care from 8.0 percent with conventional treatment to 4.6 percent (P<0.04, with adjustment for sequential analyses). The benefit of intensive insulin therapy was attributable to its effect on mortality among patients who remained in the intensive care unit for more than five days (20.2 percent with conventional treatment, as compared with 10.6 percent with intensive insulin therapy, P=0.005). The greatest reduction in mortality involved deaths due to multiple-organ failure with a proven septic focus. Intensive insulin therapy also reduced overall in-hospital mortality by 34 percent, bloodstream infections by 46 percent, acute renal failure requiring dialysis or hemofiltration by 41 percent, the median number of red-cell transfusions by 50 percent, and critical-illness polyneuropathy by 44 percent, and patients receiving intensive therapy were less likely to require prolonged mechanical ventilation and intensive care.

conclusionsIntensive insulin therapy to maintain blood glucose at or below 110 mg per deciliter reduces morbidity and mortality among critically ill patients in the surgical intensive care unit.

Indexed as

Hospital MortalityAPACHEBlood GlucoseCritical CareCritical IllnessFemaleHumansHypoglycemic AgentsInsulinIntensive Care UnitsLength of StayLogistic ModelsMaleMiddle AgedPostoperative CareProspective StudiesBlood GlucoseHypoglycemic AgentsInsulin

Identifiers

PMID11794168
OpenAlexW1980717583

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

and 15 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.